Published in TB and Outbreaks Week, February 2nd, 2010
"In this study, we report the role of methionine sulfoxide reductase B (MsrB) in resistance to ROI by constructing a msrB mutant (MS Delta msrB) and MsrA/B double mutant (MS Delta msrA/B) strains of M. smegmatis and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week